Oct 04 2023
The global market for cannabidiol (CBD) grew from $6.82 billion in 2022 to $9.4 billion in 2023 at a compound annual growth rate (CAGR) of 37.8%. According to a report by Research and Markets, the cannabidiol market is expected to grow from $9.4 billion in 2023 to $31.85 billion by 2027 at a CAGR of …
Jul 24 2023
According to a new randomized, controlled trial, the marijuana compound cannabidiol (CBD) “provides symptom relief in patients with gastroparesis and improves the tolerance of liquid nutrient intake”. The study is published in the journal Clinical Gastroenterology and Hepatology, and is conducted by researchers at the Mayor Clinic. The objective of the study was “compare effects …
Jun 26 2023
The Tennessee Department of Revenue has announced a new tax on products containing cannabinoids derived from hemp, including CBD and delta-8 and delta-10 THC. The department’s Notice #23-12 states that effective July 1, 2023, “Public Chapter 423 creates a new 6% sales tax for the privilege of engaging in the business of selling products containing …
Jun 13 2023
According to newly published research the marijuana compound cannabidiol “shows potential as an abortive agent for treating migraine attacks and headache-related conditions such as spontaneous pain and anxiety”. The study is published in the peer-reviewed journal Pain, and it’s conducted by researchers at Florida Atlantic University, the Medical University of Lublin in Poland, and the …
Jun 05 2023
Acute treatment with as little as 10 mg/kg of purified CBD “can enhance social interaction preference in male mice that are otherwise socially deficient”, according to a new study that could have important implications for humans and open the door for future research. The study is available in the recent issue of the journal Advances …
May 20 2023
The results of a new study “holds promising potential in the transdermal delivery of CBD for melanoma therapy and offers a facile tool for transdermal therapies of skin tumors.” Published in the journal Biomaterials Research, the study was conducted by researchers at the Nanjing University of Chinese Medicine and the Jiangsu Province Academy of Traditional …
May 08 2023
The marijuana compound cannabidiol (CBD) used without any other epilepsy medications appears to be safe and effective “for up to 12 months in clinical practice” when used by those with Lennox-Gastaut syndrome (LGS) or Dravet syndrome. This retrospective chart review study evaluated plant-derived highly purified cannabidiol use without other medications as add-on therapy in patients …
May 05 2023
The marijuana compound cannabidiol (CBD) is a credible candidate to address alcohol-induced sleep disturbances, according to a study published in the journal Alcohol and Alcoholism. The abstract of the study was published ahead online ahead of print by the US National Library of Medicine, and it was conducted by researchers at McMaster University and St. …
May 04 2023
An interesting new study shows that CBD may serve “as an efficient active food coating agent”. The study, published in the upcoming issue of the journal ACS Applied Materials & Interfaces and published online ahead of print by the National Library of Medicine, is titled Influence of a Transparent and Edible Coating of Encapsulated Cannabidiol …
Apr 23 2023
In what researchers call “the first study to assess CBD treatment in elite athletes”, topically applied CBD was was “tolerated well by this population and resulted in only minor adverse effects”. The study was published by the Journal of Cannabis Research, with the full text of the study also epublished by the US National Library …
